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Abstract 
 This review proposes an association between the bacteria found in periodontal disease 
and the development of neural plaque contributing to Alzheimer’s disease. Periodontitis is a 
chronic gum disease that destroys gingiva and jawbone. Many different species of bacteria are 
found in periodontitis such as Porphyromonas gingivalis, an anaerobic gram-negative bacterium. 
Recent studies have shown P. gingivalis is capable of entering the bloodstream and affecting 
both the brain and organ systems within a human host. In this review, I will delve into the 
anatomy of the human mouth, explain the cause and effects of both periodontal and Alzheimer’s 
diseases, and attempt to explicate the relationship between periodontitis and Alzheimer’s disease. 
I suggest a direct correlation between the bacteria present in periodontitis and the human brain 
impacted by Alzheimer’s disease. In support of my hypothesis, I reference peer reviewed works 
and a published study detecting P. gingival in the cortex region of the brain. Additionally, in this 
paper, I hope to provide a clear correlation between the progression of gum disease and the onset 
of Alzheimer’s disease. The proposed link between P. gingival and Alzheimer’s disease suggest 
a new avenue of preventative treatment along with signs of early diagnosis. 
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PERIODONTAL DISEASE 
 The primary mode of intake for nutrition is the oral 
cavity, also known as the mouth. The human mouth is 
comprised of teeth, gums, oral mucosa, an upper jaw, a 
lower jaw, the tongue, salivary glands, the uvula, and the 
frenulum (Brichford, 2007). These components are constantly exposed to foreign elements such 
as food. Since food particles can become lodged and left behind in many crevices within the 
mouth, neglected debris can begin to infect the epithelial layers of the gums and oral mucosa. 
The warm, humid nature of the mouth leads a growth of many different species of oral bacteria. 
These bacteria are capable of infecting the gum line surround the teeth. Once this infection 
occurs, it can quickly spread to the remaining periodontium, an area that surrounds and supports 
the tooth (Posnick, 2014). 
 The Periodontium is made up of four separate parts: the gingiva, dental alveoli (tooth 
sockets), cementum, and periodontal ligaments (Madukwe, 2014). Each of these four parts plays 
a role in supporting and anchoring a tooth in a specific location. Anatomically, the root of the 
tooth is placed firmly in the dental alveoli (Madukwe, 2014). This part of the periodontium is 
surrounded by bone tissue and is not visible (Madukwe, 2014). Surrounding the root of the tooth 
is a mineral layer known as the cementum (Madukwe, 2014). The cementum contains collagen 
fibers that anchor the tooth to the dental alveoli and extend into the surrounding periodontal 
ligament (Khockt, 2012). In order to withstand the masticatory force, the collagen fibers that 
extend from the periodontal ligament to the cementum must form a strong bond between the 
tooth and the jaw (Khockt, 2012). The exterior portion of the periodontal ligament and the region 
surrounding the neck of the tooth are lined by gingiva. The gingiva, also known as the gums, is a 
Picture of the Teeth, 2019 
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keratinized epithelial layer serving as a protective barrier for the underlying bone and tissue 
(Marquez, 2004). This protective layer is the only visible area of the periodontium (Madukwu, 
2014). 
 Seated within the periodontium is the tooth. The tooth is divided into three regions: the 
root, the neck, and the crown. The crown is the visible region extending from the upper portion 
of the gingiva. It is composed of three parts: anatomical crown, enamel, and dentin (Santos-
Longhurst, 2018). Enamel is the hardest tissue in the body and helps to protect the exposed tooth 
from bacteria (Santos-Longhurst, 2018). Below the crown is the neck; a transitional area between 
the root and the crown (Santos-Longhurst, 2018). The top of the neck and the base of the crown 
are surrounded by a small gingival region known as free gingiva. This area is not anchored to the 
tooth. The gap formed by the unanchored region between the gingiva and tooth is called the 
gingival crevice or gingival sulcus (Watson, 2020). 
 Withing this shallow, narrow sulcus is a watery fluid known as gingival crevicular fluid. 
Specific to the oral cavity, the gingival crevicular fluid is released into the sulcus as an 
inflammatory exudate from the surrounding periodontal tissue (Subbarao et al., 2019). This mass 
of cells contains antibodies, and immune cells such as neutrophils, leukocytes, and their 
complement proteins (Subbarao et al., 2019). The gingival crevicular fluid plays a crucial role in 
maintaining the structure and adhesive properties of the surrounding epithelium while also 
creating an antimicrobial defense system for the periodontium (Subbarao et al., 2019). However, 
without proper oral hygiene, bacteria will begin to form dental plaque biofilm in the gingival 
crevice (Velsko et al., 2019). These biofilms will eventually lead to a level of dysbiosis, a 
microbial imbalance, in the oral cavity (Yost et al., 2015). 
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 Although many biological factors assist in maintaining a healthy oral microbiome, this 
human defense system possesses limitations. The layer of healthy bacterium forming the 
microbiome forms a complex heterogeneous microbial composition consisting of gram-positive 
and gram-negative bacteria (Berezow, 2011). The imbalance, due to either an ineffective 
immune response or a lack of competition from healthy bacteria, caused by dental plaque 
biofilms will lead to a rise of pathogenic bacteria found in the oral cavity (Berezow, 2011). 
When the tissue becomes infected with bacteria, the tissue becomes inflamed. In time, these 
infections can lead to gum disease. 
 Gum disease can be classified into seven categories 
depending on the degree of infection. These seven 
categories are gingivitis, periodontitis, chronic 
periodontitis, aggressive periodontitis, periodontitis as a 
manifestation of systemic disease, necrotizing ulcerative 
gingivitis, abscesses of the periodontium, and combined 
periodontic-endodontic lesions (Armitage, 1999).  The 
diagnosis of oral disease is determined on a scale beginning with gingivitis and progressing to 
chronic periodontitis or one of the more severe variation of gum disease. 
 Gingivitis, known as gum disease, is inflammation of gum tissue (Newman, 2018). 
Gingivitis is a type of periodontal disease, non-destructive, that does not result in any loss of 
bone or teeth (Newman, 2018). Symptoms may include bleeding or swollen gum, change in 
color of the gums, bad breath, receding gum line, and occasional pain (Newman, 2018). The 
most common cause of gingivitis is the hardening of dental plaque on the teeth (Newman, 2018). 
The formation of dental plaque damages gingival cells that surround the infected area (Newman, 
Periodontal Disease, n.d. 
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2018). The gingival cells trigger an inflammatory signal causing an immune response in the 
gingival region (Newman, 2018). The immune response triggers a release of high concentrating 
of IgG subclass antibody-secreting cells (Kulshrestha, 2013). IgG is the main immunoglobulin 
found in human blood (Kulshrestha, 2013). This protein contains long-term antibodies used to 
fight a variety of infections (Kulshrestha, 2013). Although this IgG release is a necessary 
immune response for the destruction of infections bacterium, healthy gingival cells are also 
killed as collateral damage (Newman, 2018). 
 After IgG antibodies destroy both abnormal and healthy bacteria, any remaining 
infectious bacteria are able to progress. As the infection advances, the gingiva begins to separate 
from the neck of the tooth producing a pocket larger than the aforementioned gingival sulcus 
(Kinane, 1999). Infectious bacteria will then occupy and proliferate within this pocket leading to 
the formation of dental plaque below the neck of the tooth (Loesche, 1996). At this stage, dental 
plaque will spread to the dental alveoli, gingiva, cementum, and periodontal ligament (Loesche, 
1996). Since this region is difficult to reach and painful to clean, lack of abrasion creates an 
environment that is conducive to the calcification of dental plaque (White, 1997). The 
calcification of dental plaque then forms dental calculus (White, 1997). Composed primarily of 
calcium phosphate, dental calculus can form both supragingival and subgingival deposits in the 
gingiva (White, 1997). Supragingival calculus have been found to cause gingival recession 
promoting further infection withing the periodontium. If left untreated, dental calculus will lead 
to the onset of periodontitis (White, 1997). 
 Periodontitis is a chronic disease that affects and destroys the gum tissue and bone that 
support the teeth (Mehrotra, 2019). This disease is found in both developing and developed 
countries affecting nearly half the world’s population (Nazir, 2017). There are two main 
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classifications of periodontal disease: chronic periodontitis and aggressive periodontitis 
(Mehrotra, 2019). These two classifications of periodontitis are classified by the level of 
degradation in the surrounding periodontium (Guo, 2016). More specifically, this level is 
measured by probing and recording at six sites around the tooth: mesio-buccal, mid-buccal, 
mesio-lingual/palatal, disto-buccal, mid-lingual, and disto-lingual/palatal sites. (Guo, 2016). The 
measurements are recorded as slight (1-2 mm attachment loss), moderate (3-4 mm attachment 
loss), and severe (>5 mm of attachment loss) (Vilardi, 2017). Periodontitis classification extends 
further to generalized and local. Generalized periodontitis affects more than 30% of the mouth, 
and localized affects less than 30% of the mouth (Wiebe, 2000). As the disease progresses, 
bacterial accumulation increases exponentially. 
 Over 700 bacterial species have been found in the oral cavity (Gao et al, 2018). The 
hypothesis of periodontal disease progression is described as the orange complex bacteria 
(Periodontitis: the Complex, n.d.). Bacteria in the mouth adhere to the pellicle, a protein film of 
the tooth, to avoid being flushed out by the gingival crevicular fluid (Periodontitis: the Complex, 
n.d.) These bacteria, also known as the early colonizers, form in the dental crevice (Periodontitis: 
the Complex, n.d.). Since they are moderately pathogenic, they are labeled as green complex. 
The green complex bacteria include: Eikenella corrodens, Capnozytophaga sputigena, 
Aggregatibacter actinomycetemcomitans, Campylobacter gracilis, and Capnocytophaga 
ochracea (Carrouel et al, 2016). The orange complex hypothesis predicts that green complex 
vacteria will lead to the highly pathogenic bacteria of the red complex (Periodontitis: the 
Complex, n.d.). The orange complex bacteria includes: Campylobacter gracilis, Campylobacter 
rectus, Fusobacterium necleatum, Parvimonas micra, Prevotella intermedia, and Prevotello 
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nigrescens (Carrouel et al, 2016). As the host’s oral health condition worsens, a living condition 
is created for strictly anaerobic bacteria also known as the red complex (Carrouel et al, 2016). 
 The anaerobic bacteria classified within the red complex include: Porphyromonas 
gingivalis, Tannerella forsythia, and Treponema denticola (Carrouel et al, 2016). The red 
complex bacteria, typically inhabiting adjacent colonies, are proposed to destroy tissue 
cooperatively (How et al, 2016). Porphyromonas gingivalis is a gram-negative anaerobic 
bacterium which forms black-pigmented colonies (How et al, 2016). This red complex bacterium 
relies on the fermentation of amino acids for energy production (How et al, 2016). Poor oral 
hygiene and compromised periodontium health lead to increase protein concentrations within 
crevices. The amino acids that make up these proteins 
provide P. gingivalis with enough energy to thrive in a 
deep periodontal pocket (How et al, 2016). P. gingivalis 
deploys many virulence factors such as fimbriae, 
lipopolysaccharides, and proteases (How et al, 2016). 
These factors aid P gingivalis in things such as bone resorption, adhesion to host membranes, 
and degradation of plasma proteases inhibitors (How et al, 2016). An important virulence 
technique is the use of arg-gingipain and lys-gingipain cysteine proteinase (Kataoka et al, 2014).  
This technique causes abnormal immune and inflammatory responses within the host and further 
degrades tissue proteins (Kataoka et al, 2014). The lys-gingipain is encoded by a single gen kgp 
(Kataoka et al, 2014). However, arg-gingipain is capable of being encoded by two genes rgpA 
and rgpB (Kataoka et al, 2014). The kgp-rgpA-rpgB triple mutation is responsible for lesion 
formation and inducing abscesses of the mouth (Yoneda et al, 2003). These abrasions are 
worsened by normal oral functions such as chewing. These lesions provide the red complex 
Porphyromonas gingivalis, 2016 
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bacteria access to the host’s bloodstream. Once in the bloodstream, these bacteria are capable of 
traveling throughout the body and affecting the host’s organs. These bacteria have been linked to 
diseases such as hypertension and diabetes. 
Alzheimer’s disease 
 Alzheimer’s disease is a chronic neurodegenerative disease (Weller et al, 2018). This 
disease is irreversible and accounts for 60-70% of all dementia cases (World Health 
Organization, 2019). Early symptoms of Alzheimer’s may include forgetfulness, loss of time, 
and inability to recall familiar places (World Health Organization, 2019). Alzheimer’s disease is 
a progressive disease with middle stage symptoms including the inability to remember recent 
events and people’s names, recall details about familiar locations, communicate effectively, and 
complete familiar tasks (World Health Organization, 2019). Eventually, this disease will lead to 
late stage symptoms which include confusion with time, forgetting places such as home, 
difficulty recognizing relatives, and difficulty walking (World Health Organization, 2019). These 
symptoms are brought on by a physiological change in the brain that triggers neuron 
degeneration.  
 Inside the cell membrane of the brain, APP genes regulate the production of a protein 
called amyloid precursor protein (APP gene, n.d.). Located across a phospholipid bilayer, the 
amyloid precursor protein reaches inside and outside of the cell. This precursor protein helps 
repair and grow neurons in the brain. However, the amyloid precursor protein can become worn 
and need to be recycled (APP gene, n.d.).  When the protein needs to be recycled, enzymes 
cleave the protein in two places (O’Brien et al, 2011). α-secretase and γ-secretase cleave the 
amyloid precursor protein in two locations (Chow et al, 2011). Cleaving takes place both inside 
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and outside of the phospholipid bilayer. This produces a soluble peptide fragment that is 
harmless to the human brain (Moore, 2020). 
 When β-secretase replaces α-secretase, a non-soluble monomer, known as amyloid beta, 
is formed (Moore, 2020). As these monomers are produced, they clump together forming 
amyloid beta plaque (Moore, 2020). This plaque is comprised of amyloid beta proteins, glial 
debris, and neuritic debris (Sheng et al, 1997). This plaque formation interrupts the crucial 
function of astrocytes and microglia promote neuron development by clearing cellular debris in 
the central nervous systems (Fakhoury, 2018). Astrocytes and microglia promote neuron 
development by clearing cellular debris in the central nervous system (Fakhoury, 2018). In 
response to the invasive plaque, the microglial cells activate an abnormally large neuroimmune 
response (Lenz, 2018). In an attempt to destroy the 
amyloid beta plaque, the neuroimmune response causes 
neuroinflammation resulting in the dysfunction and 
degeneration of the microglia (Clayton, 2017).  
 The accumulation of beta amyloid plaque between neurons generates a disruption of 
chemical signaling impairing communication between the synapses (What Happens to, n.d.). 
Unable to transmit signal, the pathway between the soma, the area of the where neuro-signals 
join, of the neuron and synapse begin to degrade (Clayton et al, 2017). The degradation of these 
pathways directly affects the dendrite; the dendrite is the internal components of the neuron 
located between the soma and synapse which receives impulses from other cells (Dharani, 2015). 
Within the neuron, microtubules provide structure and transport substances throughout the cell 
(Alberts et al, 2002). These microtubules are composed of thirteen filamentous strands composed 
Neuron Anatomy, n.d. 
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of chain proteins called tubulin (Alberts et al, 2002). These filamentous strands deliver 
neurotransmissions from the soma to the synapsis (Alberts et al, 2002). 
 Another component of the microtubule is the Tau protein. Tau proteins line the 
microtubules of the neuron to stabilize and maintain the structure of the microtubule filaments 
(Mandelkow et al, 2012). As the neuron degrades, the microtubule begins to dephosphorylate 
causing a release of tau proteins throughout the neuron (Mandelkow et al, 2012). These free-
floating proteins begin to form filaments throughout the neuron (Guo et al, 2014). The buildup of 
tau proteins produces neurofibrillary tangles (Lewis et al, 2000). As neurofibrillary tangles begin 
to aggregate, they be begin degrading the neuron. Eventually, the neuron loses all synaptic 
communication and dies (Johnson et al, 2004).  
 Neurofibrillary tangles begin by forming in neurons of the hippocampus (Furcila et al, 
2019). The hippocampus is important in the formation of memories, learning abilities, and 
emotions (Tyng et al, 2017). As neurofibrillary tangles develop in the hippocampus, early stages 
of Alzheimer’s disease such as difficulty forming memories begin to show (Wint et al, 2014). As 
neurofibrillary tangle concentrations increase within the hippocampus, they begin spreading to 
other regions of the brain. Similar to results within the hippocampus, the neurofibrillary tangles 
cause atrophy throughout the entire brain (Wint et al, 2014). This gives rise to brain 
abnormalities resulting in loss of cognitive function. Recent studies suggest that this 
neuroinflammatory. Recent studies suggest that this neuroinflammatory response began by 
infiltration of periodontal bacteria entering the brain via the bloodstream (Teixeira et al, 2017).  
Periodontal Disease Linked to Alzheimer’s Disease 
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 Periodontitis is a chronic disease that causes inflammation and destruction of gingiva and 
tooth-supporting bone in the mouth. Cases of periodontitis are very common among the 
American population with nearly 50% of adults suffering from periodontitis (CDC: Half of, 
2012). The likelihood of developing periodontitis increases with age. Individuals over the age of 
65 and suffering from Alzheimer’s were believed to have suffered from periodontitis due to the 
inability to perform adequate oral health upkeep. However, recent studies suggest periodontitis is 
the causal root of both dementia and Alzheimer’s disease (Cerajewska et al, 2016). Since 
periodontitis is a chronic disease, periodontal bacteria exposure is far greater in elderly 
individuals. Once present in above threshold concentrations, periodontal bacteria will continue to 
persist, even after regular brushing (Loesche et al, 2001). When left untreated, these infectious 
periodontal bacteria enter the bloodstream. Recent studies suggest these bacteria traveled to 
organs such as the pancreas, heart, and brain in individuals affected by periodontitis (Iwai, 2009). 
 Due to the destructive nature of the bacterium, Porphyromonas gingivalis, a red complex 
pathogen in chronic periodontitis, has been labeled as a risk factor for developing amyloid beta 
plaque, dementia, and Alzheimer’s disease (Ide et al, 2016). The possible mechanism of 
periodontal disease being an underlying factor in the development of Alzheimer’s disease was 
suggested after the completion of an observational study. The study graded Alzheimer’s disease 
patients on a scale of cognition, Alzheimer’s disease assessment scale-cognitive, and mini mental 
state examination scale (Carotenuto et al, 2018). Over a 6-month study, Alzheimer’s disease 
patients who currently suffered from chronic periodontitis reported a decline in basic function of 
cognition (Carotenuto et al, 2018). The results prompted the hypothesis that periodontal bacteria 
are directly linked to the development of Alzheimer’s disease. 
Literature Review 
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 Cortexyme Incroporate, a biopharmaceutical company, states they are altering the effects 
of degenerative diseases in the human body. Due to factors such as aging, Cortexyme 
hypothesizes that our body progressively loses the ability to protect itself from pathogens such 
Porphyromonas gingivalis. Cortexyme’s hypothesis states that the blood brain barrier becomes 
more permeable with age (Cortexyme initiates new, 2019). Increased permeability allows 
bacteria such as Porphyromonas gingivalis to flow from the mouth to the brain (Cortexyme 
initiates new, 2019). Once in the brain bacteria begin to attack brain cells. During this time, 
Porphyromonas gingivalis begins to secrete gingipains to increase the bacterium’s virility. 
Although the brain retaliates with a neuroimmune response, 
the gingipains are capable of protecting Porphyromonas 
gingivalis (Cortexyme initiates new, 2019). The gingipains 
respond by degrading cytokines and triggering the formation 
of amyloid beta plaques (Cortexyme initiates new, 2019). As 
the plaque continues to buildup, chemical signaling between 
neurons is stopped and microtubules along the skeleton of the 
neuron breakdown (Cortexyme initiates new, 2019). This 
degradation leads to an increased concentration of neurofibrillary tangles and results in the death 
of neuron involved. Cortexyme believes the use of a competitive inhibitor can stop the gingipain, 
virtually starving Porphyromonas gingivalis (Olsen et al, 2014). 
 Coxtexyme began a series of preclinical trials to determine the association between 
Porphyromonas gingivalis and Alzheimer’s disease. Aiming to find the presence of gingipains 
and P. gingivalis, the study examined the post-mortem DNA cortex tissues in the brains of 
Alzheimer’s patients (Cortexyme Presents Data, 2020). Cortexyme’s post-mortem study revealed 
Olsen et al, 2015 
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that over 90% of the brains affected by Alzheimer’s disease also tested positive for the presence 
of P. gingivalis (Cortexyme Presents Data, 2020). Cortexyme used qPCR technology to detect 
Porphyromonas gingivalis in human brain tissue and cerebral spinal fluid (Specific methods, 
2019). Using advanced sequencing techniques, they were able to determine the positive presence 
of both Porphyromonas gingivalis and gingipains in brain samples using bacteria specific 
primers: hmuY, 16s, and Kgp (Specific methods, 2019). Next, Porphyromonas gingivalis specific 
primers were selected using DNA fragments: forward 
sequence ACCTTTAAACCCAATAAATC, reverse 
sequence ACGAGTATTGCATTGAATG, and 
fluorescent probe CGCTCGCATCCTCCGTATTAC 
(Specific methods, 2019). After the qPCR, the data 
was able to definitively confirm the presence of 
Porphyromonas gingivalis and gingipains in a brain suffering from Alzheimer’s disease 
(Specific methods, 2019). After the positive identification of gingipains and the bacterium 
Porphyromonas gingivalis in the human brain and spinal fluid, Cortexyme is hoping to find an 
inhibitor to block gingipain function and induce a successful neuroimmune response (Wang, 
2019) Although the inhibitor is still in the preclinical trial phase, Cortexyme’s study and 
resulting hypothesis may stop the progression of Alzheimer’s in patients exhibiting periodontitis. 
Discussion 
 Gum disease is one of the most common diseases throughout America. If left untreated, 
gum disease can progress from gingivitis to chronic periodontitis. Periodontitis is a disease that 
infects and damages the bone and tissue that supports the tooth. The bacterium known to cause 
periodontitis is Porphyromonas gingivalis. This bacterium has been linked to coronary artery 
Stoye, 2019 
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disease, rheumatoid arthritis, and complications in diabetes (Periodontitis, 2020). Recent 
research has been able to positively identify Porphyromonas gingivalis and gingipains in the 
brains of those suffering from Alzheimer’s disease. After entering the bloodstream through the 
mouth, the bacterium travels throughout the host’s body infecting the organs. Companies, such 
as Cortexyme Inc, are developing drugs to combat Porphyromonas gingivalis’s defense. They 
hope this would starve out the bacterium causing these diseases. 
 I propose a bacterial vaccine to eradicate the body of the bacterium Porphyromonas 
gingivalis. After exposure, the body builds up defenses against the bacterium in the form of 
antibodies. However, Porphyromonas gingivalis is capable of evading the host’s defenses by 
releasing gingipains. A bacterial vaccine composed of deactivated Porphyromonas gingivalis 
and gingipains would help the host build antibodies. This vaccine could be administered by a 
dentist after the identification of Porphyromonas gingivalis. This method could be used as a 
preventive measure against periodontitis and linked diseases. 
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